Ocular Sarcoidosis Open Label Trial of ACTHAR Gel

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2022

Conditions
Ocular SarcoidosisPanuveitisAnterior Uveitis
Interventions
DRUG

Repository Corticotropin Injection

"Treatment with ACTHAR Gel for 24 weeks~* Initial treatment with 80 units daily for ten days (induction phase)~* Maintenance treatment with 80 units twice weekly (maintenance phase)"

DRUG

Repository Corticotropin Injection -Treatment Extension

24 open label extension permitted in subjects who respond to treatment

Trial Locations (1)

44145

Cleveland Clinical Foundation, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

The Cleveland Clinic

OTHER